SIRPA and hematopoietic and lymphoid cell neoplasm: All target cell lines tested, which included both epithelial and hematopoietic cancer cell lines (DLD1, Raji, MC38) expressed the SIRPα ligand CD47 (Supplementary Figure 1C).